NASDAQ: USARUsa Rare Earth Inc Stock
$17.22-0.26 (-1.49%)
Updated Dec 5, 2025
USAR Price
$17.22
Fair Value Price
N/A
Market Cap
$2.28B
52 Week Low
$5.56
52 Week High
$43.98
P/E
-5.98x
P/B
-37.72x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$254.15M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-6.09
Operating Cash Flow
-$25M
Beta
0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
USAR Overview
USA Rare Earth, Inc. operates as a magnet manufacturing company. The Company develops a NdFeB magnet manufacturing, minerals supply, extraction, and processing plant. USA Rare Earth serves defense, automotive, aviation, industrial, medical, and consumer electronics industries in the United States.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine USAR's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important USAR news, forecast changes, insider trades & much more!
USAR News
Overview
Due Diligence Score
–
Industry Average (21)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how USAR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
USAR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
USAR is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
USAR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more USAR due diligence checks available for Premium users.
Valuation
USAR fair value
Fair Value of USAR stock based on Discounted Cash Flow (DCF)
Price
$17.22
Fair Value
-$0.01
Undervalued by
121,956.80%
USAR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
USAR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.98x
Industry
8.31x
Market
46.7x
USAR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-37.72x
Industry
2.41x
USAR's financial health
Profit margin
Revenue
$0.0
Net Income
-$156.7M
Profit Margin
0%
USAR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$323.3M
Liabilities
$368.6M
Debt to equity
-6.09
USAR's short-term assets ($258.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
USAR's long-term liabilities ($352.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
USAR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
USAR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.8M
Investing
-$7.1M
Financing
$145.8M
USAR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
USAR vs Mining Stocks
Usa Rare Earth Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.